We are pleased to invite you to a high-energy, in-person event bringing together the industry and stakeholders from across the life sciences ecosystem to discuss the pressures and opportunities shaping the sector today.
You can expect concise, candid sessions that translate geopolitical turbulence, security and cyber resilience, evolving regulation and market access, and data-driven innovation into practical next steps for your organisation.
You will hear forward-looking perspectives on where policy and markets are heading, what to prioritise now, and how to convert compliance and risk management into value creation.
As always, engagement is central: lively Q&A after each session, and ample networking to compare experiences, test assumptions, and distil actions.
Progam
08:30: Registry and breakfast
09:00 – 09:10: Welcome
Martin Dræbye Gantzhorn, Partner, Gorrissen Federspiel, Life Sciences
09:10 – 09:30: The Life Sciences Industry facing global turmoil
Perspectives on the framework conditions of the Danish and the EU Life Sciences industries navigating unprecedented global turmoil.
Mads W. Ø. Larsen, 1st Vice Chair, The Danish Association of the Pharmaceutical Industry
09:30 – 10:00: Current security threats against the Danish Life Sciences industry
The industry faces a time of concerns and threats – mitigative steps to consider.
Danish Security and Intelligence Service, PET
10:00 – 10:20:Building Cyber Resilience: A Mental and Operational Transformation
Key information security risk learnings from working in an ever-changing corporate environment, including experiences from the Novonesis merger.
Anne Sofie Roed Rasmussen, Chief Information Security Officer (CISO), Novonesis
10:20 – 10:40: Cyber security from a legal risk and value creation perspective
Recent developments and key topics to consider.
Tue Goldschmieding, Partner, Gorrissen Federspiel, Digital Business
10:40 – 11:00: Networking
11:00 – 11:20: European Health Data Space
The EHDS may offer great opportunities to patients, society and industry. But when and how will it operate? Pitfalls to consider?
Kenneth Forstrøm Jensen, Health Impact Lead, Roche
11:20 – 11:40: Public HTA Regulations
Since 12 January 2025, the HTA system has been in operation. What are the key learnings and what should the industry be mindful of?
Trine Pilgaard, Head of Market Access, Pfizer
11:40 – 12:00: Medical Devices
In a decade of regulatory turmoil – what to look out for and a current state of the union focusing on recent Danish and European developments.
Jeppe Larsen, Head of Department, Danish Medicines Agency
12:00 – 13:00: Networking and lunch
Time and Venue
Date: 9 December 2025
Time: 08:30 – 13:00
Venue: Axel Towers, Axeltorv 2, 1609 Copenhagen
Certificate of Participation
A certificate can be issued in accordance with the rules on continuing mandatory training for lawyers and assistant attorneys upon participation in at least one more seminar.
Registration
The seminar is free to participate in.
Please register your attendance via the form below.